ACTIVE

Dr. J. RODENBACH

Financial year 2023 · Closed on 31/12/2023

Net result5,7 k €+16 349,6 %over 1 year
Gross margin99,6 k €+66,7 %over 1 year
Equity248,6 k €+2,4 %over 1 year

Identity

Source · BCE/KBO

Dr. J. RODENBACH is a Private limited company incorporated in 1998. Its main activity is: Specialist medical practice activities. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0462.681.684
Incorporation
17/02/1998
Legal form
Private limited company
Registered office
Antoon Catriestraat 1
9031 Gent · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2023
Joint committees (1)
  • 330
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 18 filings

Trend over 17 financial years

20232022202120202019
Income statement
Gross margin99,6 k €59,7 k €72,1 k €61 k €99 k €
EBITDA92,4 k €56,2 k €66,2 k €55,7 k €94 k €
Operating result12,1 k €4 k €4,9 k €1,1 k €12,4 k €
Net result5,7 k €34,8 €243,8 €231,6 €7,1 k €
Balance sheet
Equity248,6 k €242,9 k €242,8 k €242,6 k €242,4 k €
Total assets504,1 k €491,2 k €409,5 k €418,8 k €383,3 k €
Cash68,2 k €29 k €66,8 k €44,6 k €46,7 k €
Debts253,4 k €248,2 k €166,6 k €166,1 k €131 k €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2023

1 active · 2 ended

Active mandates

Jan Rodenbach

Director

Active

Ended mandates

Jan Rodenbach

Administrator - manager

Ended
Jan Rodenbach

Manager

Ended

Other companies at this address

Antoon Catriestraat 1 9031 Gent
CompanyCBE no.
1032.371.988

Full financial information

Source · NBB
202320222021202020192018
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202301/01/202201/01/202101/01/202001/01/201901/01/2018
Closing of the financial year31/12/202331/12/202231/12/202131/12/202031/12/201931/12/2018
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date14/11/202406/10/202331/08/202230/12/202131/12/202030/09/2019
General meeting11/10/202431/08/202324/08/202211/10/202102/12/202012/09/2019
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 18 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202311/10/202414/11/2024DutchPDF
Micro model31/12/202231/08/202306/10/2023DutchPDF
Micro model31/12/202124/08/202231/08/2022DutchPDF
Micro model31/12/202011/10/202130/12/2021DutchPDF
Micro model31/12/201902/12/202031/12/2020DutchPDF
Micro model31/12/201812/09/201930/09/2019DutchPDF
Micro model31/12/201708/10/201830/11/2018DutchPDF
Micro model31/12/201606/10/201730/11/2017DutchPDF
Abridged model31/12/201521/10/201629/11/2016DutchPDF
Abridged model31/12/201431/07/201531/08/2015DutchPDF
Abridged model31/12/201305/08/201429/08/2014DutchPDF
Abridged model31/12/201205/08/201329/08/2013DutchPDF
Abridged model31/12/201121/11/201214/12/2012DutchPDF
Abridged model31/12/201031/08/201130/09/2011DutchPDF
Abridged model31/12/200915/10/201029/11/2010DutchPDF
Abridged model31/12/200813/11/200930/12/2009DutchPDF
Abridged model31/12/200705/08/200829/08/2008DutchPDF
Abridged model31/12/200630/09/200729/10/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2023

1 active · 2 ended

Active mandates

Jan Rodenbach

Director

Active

Ended mandates

Jan Rodenbach

Administrator - manager

Ended
Jan Rodenbach

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates22/03/2024
    WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares28/03/2018
    KAPITAAL - AANDELEN
    PDF
  • Other03/06/2015
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Capital / shares12/03/2014
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Capital / shares15/04/2004
    KAPITAAL - AANDELEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2023
    Annual accounts 20235,7 k €↑
  2. 2022
    Annual accounts 202234,8 €↓
  3. 2021
    Annual accounts 2021243,8 €↑
  4. 2021
    Name changeDOKTER RODENBACH J.
  5. 2020
    Annual accounts 2020231,6 €↓
  6. 2019
    Annual accounts 20197,1 k €↑
  7. 2018
    Annual accounts 20185,8 k €↓
  8. 2017
    Annual accounts 201710,7 k €↓
  9. 2016
    Annual accounts 201614,9 k €↓
  10. 2015
    Annual accounts 201518,8 k €↓
  11. 2014
    Annual accounts 201435,5 k €↓
  12. 2013
    Annual accounts 201368,1 k €↓
  13. 2012
    Annual accounts 201278,7 k €↓
  14. 2011
    Annual accounts 2011101,9 k €↑
  15. 2010
    Annual accounts 201048,8 k €↓
  16. 2009
    Annual accounts 200963,8 k €↓
  17. 2008
    Annual accounts 200875,1 k €↑
  18. 2007
    Annual accounts 200738,5 k €
  19. 2007
    Name changeDr. J. RODENBACH
  20. 17/02/1998
    IncorporationPrivate limited company